Eurazeo: IdInvest Partners divests TeleClinic
(CercleFinance.com) - Eurazeo has announces the divestment of TeleClinicby, a leading telemedicine platform in Germany, by Idinvest Partners.
This sale has been made to the Swiss group Zur Rose, a global pharmaceutical player and European leader in e-pharmacy.
"Founded in 2015 and part of Eurazeo's Venture portfolio since 2018, TeleClinic has been a pioneer in the development of teleconsultation and electronic prescriptions reimbursed by the German social security system," it said.
"This sale, taking place a mere 2 years after its original investment, confirms Eurazeo's Venture strategy, established more than 5 years ago in the digital health sector."
Copyright (c) 2020 CercleFinance.com. All rights reserved.
This sale has been made to the Swiss group Zur Rose, a global pharmaceutical player and European leader in e-pharmacy.
"Founded in 2015 and part of Eurazeo's Venture portfolio since 2018, TeleClinic has been a pioneer in the development of teleconsultation and electronic prescriptions reimbursed by the German social security system," it said.
"This sale, taking place a mere 2 years after its original investment, confirms Eurazeo's Venture strategy, established more than 5 years ago in the digital health sector."
Copyright (c) 2020 CercleFinance.com. All rights reserved.